abstract |
(57) [Summary]nCompounds of formula (I) are useful in treating gastrointestinal disorders associated with neutralizing motilin receptor disorders. These compounds compete for the motilin receptor with erythromycin and motilin. In addition, the compounds are antagonists of the contractile smooth muscle response to their ligand. |